Chronic obstructive pulmonary disease. A worldwide problem

Medical Clinics of North America

Volumn 96, Issue 4, 2012, Pages 671-680

  Soriano, Joan B ^a   Lamprecht, Bernd ^b  

^a Recinte Hospital Joan March   (Spain)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Chronic obstructive pulmonary disease; Epidemiology; Prevalence; Smoking; Worldwide

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOFUEL; COAL; FUEL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIR POLLUTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ASTHMA; BIOMASS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEMOGRAPHY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIARRHEA; DISEASE COURSE; DUST EXPOSURE; FUME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG INJURY; LUNG TUBERCULOSIS; MORTALITY; NEOPLASM; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SMOKING; SPIROMETRY;

COST OF ILLNESS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; MASS SCREENING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPIROMETRY; WORLD HEALTH;

EID: 84863817827     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.02.005     Document Type: Review

References (72)

1. International COPD Coalition. Quick facts about COPD. Available at: Accessed September 9, 2011. http://www.internationalcopd.org/materials/patients/learn/facts.aspx.
2. Bousquet J., Kiley J., Bateman E.D., et al. Prioritized research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010, 36:995-1001.
3. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
4. European Respiratory Society European lung white book 2003, European Respiratory Society Journals, Huddersfield (UK).
5. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
6. Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Available at: Date last updated: 2007 [accessed]. http://www.who.int/gard/publications/GARD%2520Book%25202007.pdf.
7. Stockley R.A., Mannino D., Barnes P.J. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009, 6:524-526.
8. Mannino D.M., Buist A.S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370:765-773.
9. Chapman K.R., Mannino D.M., Soriano J.B., et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006, 27:188-207.
10. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
11. Bellamy D., Bouchard J., Henrichsen S., et al. International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 2006, 15(1):48-57.
12. Peces-Barba G., Barberà J.A., Agustí A., et al. Arch Bronconeumol 2008, 44:271-281. [in Spanish].
13. O'Reilly J., Jones M.M., Parnham J., et al. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. BMJ 2010, 340:c3134.
14. Lopez A.D., Shibuya K., Rao C., et al. The Global burden of COPD: future COPD projections. Eur Respir J 2006, 27:397-412.
15. Murray C.J., Lopez A.D., Black R., et al. Global burden of disease 2005: call for collaborators. Lancet 2007, 370:109-110.
16. Jensen H.H., Godtfredsen N.S., Lange P., et al. Potential misclassification of causes of death from COPD. Eur Respir J 2006, 28:781-785.
17. Mathers C.D., Roncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:2011-2030.
18. Soriano J.B., Zielinski J., Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009, 29(374):721-732.
19. Halbert R.J., Natoli J.L., Gano A., et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006, 28:523-532.
20. Menezes A.M., Perez-Padilla R., Jardim J.R., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881.
21. Buist A.S., McBurnie M.A., Vollmer W.M., BOLD Collaborative Research Group, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750.
22. Christensen K., Doblhammer G., Rau R., et al. Ageing populations: the challenges ahead. Lancet 2009, 374:1196-1208.
23. Shafey O., Erisksen M., Ross H., et al. The tobacco atlas 2009, American Cancer Society and the World Lung Foundation, Geneva.
24. Soriano J.B., Ancochea J., Miravitlles M., et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2010, 36:758-765.
25. Vasankari T.M., Impivaara O., Heliövaara M., et al. No increase in the prevalence of COPD in two decades. Eur Respir J 2010, 36:766-773.
26. Celli B.R. The light at the end of the tunnel: is COPD prevalence changing?. Eur Respir J 2010, 36:718-719.
27. Cerveri I., De Marco R. What makes large epidemiological studies comparable?. Eur Respir J 2010, 36:720-721.
28. Soriano J.B., Miravitlles M., Borderías L., et al. Arch Bronconeumol 2010, 46:522-530. [in Spanish].
29. McBurnie MA, Nizankowska-Mogilnicka E, Nielsen R, et al. Worldwide under- and over-diagnosis of COPD: results from the BOLD study. Abstract Presented at the ERS (European Respiratory Society) Congress 2009. Vienna, 2009. abstract: P1016.
30. Lopez A.D., Mathers C.D. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol 2006, 100:481-499.
31. Enright P., Vollmer W.M., Lamprecht B., et al. Quality of Spirometry tests performed by 9893 adults in 14 countries: The BOLD Study. Respir Med 2011, 105:1507-1515.
32. 1/FVC <0.70 to detect airway obstruction? No. Chest 2010, 138:1037-1040.
33. 1/FVC <0.70 to detect airway obstruction? Yes. Chest 2010, 138:1040-1042.
34. Le groupe Pulmonaria, Quanjer P.H., Enright P.L., et al. Rev Mal Respir 2010, 27:1003-1007. [in French].
35. Quanjer P., Enright P.L., Ruppel G., et al. GOLD and the fixed ratio. Eur Respir J 2011, 38:482-484.
36. García-Rio F., Soriano J.B., Miravitlles M., et al. Subjects " over-diagnosed" as COPD by the 0.7 fixed ratio have a poor health-related quality of life. Chest 2011, 139:1072-1080.
37. Chobanian A.V. Shattuck Lecture. The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med 2009, 361:878-887.
38. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985, 14:32-38.
39. Blanc P.D., Menezes A.M., Plana E., et al. Occupational exposures and COPD: an ecological analysis of international data. Eur Respir J 2009, 33:298-304.
40. Ezzati M., Hoorn S.V., Rodgers A., et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003, 362:271-280.
41. Hnizdo E., Sullivan P.A., Bang K.M., et al. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002, 156:738-746.
42. Blanc P.D., Iribarren C., Trupin L., et al. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax 2009, 64:6-12.
43. de Meer G., Kerkhof M., Kromhout H., et al. Interaction of atopy and smoking on respiratory effects of occupational dust exposure: a general population-based study. Environ Health 2004, 3(1):6.
44. Sørheim I.C., Johannessen A., Gulsvik A., et al. Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax 2010, 65(6):480-485.
45. Stoller J.K., Aboussouan L.S. α1-Antitrypsin deficiency. Lancet 2005, 365:2225-2236.
46. Lange P., Parner P., Vestbo J., et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998, 339:1194-1200.
47. Menezes A.M., Hallal P.C., Perez-Padilla R., et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J 2007, 30:1180-1185.
48. Ciscar J.C., Iglesias A., Feyen L., et al. Physical and economic consequences of climate change in Europe. Proc Natl Acad Sci U S A 2011, 108:2678-2683.
49. Tashkin D.P. Smoked marijuana as a cause of lung injury. Monaldi Arch Chest Dis 2005, 63:93-100.
50. Aldington S., Williams M., Nowitz M., et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007, 62:1058-1063.
51. Torres-Duque C., Maldonado D., Pérez-Padilla R., et al. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008, 5:577-590.
52. Anonymous COPD-more than just tobacco smoke. Lancet 2009, 374:663.
53. Eisner M.D., Anthonisen N., Coultas D., et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182:693-718.
54. U.S.Department of Health and Human Services The health consequences of smoking: a report of the surgeon general 2004, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta (GA).
55. Lundbäck B., Lindberg A., Lindstrom M., et al. Obstructive lung disease in Northern Sweden studies. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003, 97:115-122.
56. Lindberg A., Bjerg-Backlund A., Ronmark E., et al. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006, 100:264-272.
57. Mannino D.M., Buist A.S., Petty T.L., et al. Lung function and mortality in the United States: data from the first National Health and Nutrition Examination Survey follow up study. Thorax 2003, 58:388-393.
58. Chilvers E.R., Lomas D.A. Diagnosing COPD in non-smokers: splitting not lumping. Thorax 2010, 65:465-466.
59. Brandt A.M. FDA regulation of tobacco-pitfalls and possibilities. N Engl J Med 2008, 359:445-448.
60. Romieu I., Riojas-Rodríguez H., Marrón-Mares A.T., et al. Improved biomass stove intervention in rural Mexico: impact on the respiratory health of women. Am J Respir Crit Care Med 2009, 180(7):649-656.
61. Perez-Padilla R., Schilmann A., Riojas-Rodriguez H. Respiratory health effects of indoor air pollution. Int J Tuberc Lung Dis 2010, 14:1079-1086.
62. Desai M., Mehta S., Smith K. Indoor smoke from solid fuels: assessing the environmental burden of disease at national and local levels 2004, World Health Organization, Geneva (Switzerland).
63. Smith K.R., Metha S., Maeusezahl-Feuz M. Indoor air pollution from household use of solid fuels. Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors 2004, 1435-1439. World Health Organization, Geneva (Switzerland). M. Ezzati, A. Lopez, A. Rodgers (Eds.).
64. Bruce N., Perez-Padilla R., Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000, 78:1078-1092.
65. Zhang J., Smith K.R. Indoor air pollution: a global health concern. Br Med Bull 2003, 68:209-225.
66. World Health Organization The World Health Report 2002: reducing risks, promoting healthy life 2002, World Health Organization, Geneva (Switzerland).
67. Global burden of disease and risk factors 2006, World Bank Publications, Washington, DC, p. 1-11. Chapter 1. A.D. Lopez, C.D. Mathers, M. Ezzati (Eds.).
68. Agusti A., Barnes P.J. What the journal would like to publish on chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182(1):1-2.
69. Cazzola M., MacNee W., Martinez F.J., et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31:416-469.
70. Pinnock H., Thomas M., Tsiligianni I., et al. The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010. Prim Care Respir J 2010, 19(Suppl 1):S1-20.
71. Agusti A., Vestbo J. Current controversies and future perspectives in COPD. Am J Respir Crit Care Med 2011, 184(5):507-513.
72. Soriano J.B., Brusasco V., Dinh-Xuan A.T. ERJ makes COPD a priority. Eur Respir J 2011, 38(5):999-1001.